Biogen (NASDAQ:BIIB) Issues FY 2024 Earnings Guidance

Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 15.000-16.000 for the period, compared to the consensus estimate of 15.460. The company issued revenue guidance of -. Biogen also updated its FY24 guidance to $15.00-16.00 EPS. Biogen […]

Related Keywords

United States ,Germany ,Canada ,America Bofa ,Priya Singhal ,Erick Rowinsky ,Needham Company ,Securities Exchange Commission ,Royal Bank ,Biogen Inc ,Canaccord Genuity Group ,Nasdaq ,Get Free Report ,Moderate Buy ,Exchange Commission ,Director Eric ,Biogen Daily ,Biogen ,Nasdaq Biib ,Biib ,Medical ,09062x10 ,Guidance ,Earnings ,Preannouncement ,